Individualized Neurodevelopmental Treatment

This study has been completed.
Sponsor:
Information provided by:
Hellenic Society for Disabled Children
ClinicalTrials.gov Identifier:
NCT00922077
First received: June 1, 2009
Last updated: June 16, 2009
Last verified: June 2009
  Purpose

The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.


Condition Intervention Phase
Cerebral Palsy
Behavioral: standard physical therapy program with emphasis on dynamic balance exercises
Phase 3

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: Individualized Neurodevelopmental Treatment

Resource links provided by NLM:


Further study details as provided by Hellenic Society for Disabled Children:

Enrollment: 1
Study Start Date: January 2008
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Detailed Description:

The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.

  Eligibility

Ages Eligible for Study:   6 Years to 9 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • spastic tetraplegia

Exclusion Criteria:

  • vision problems
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00922077

Locations
Greece
Hellenic Society for Disabled Children
Thessaloniki, Greece, 25155
Sponsors and Collaborators
Hellenic Society for Disabled Children
  More Information

No publications provided

Responsible Party: Gait Laboratory ELEPAP THESSALONIKI
ClinicalTrials.gov Identifier: NCT00922077     History of Changes
Other Study ID Numbers: 001-Nikodelis
Study First Received: June 1, 2009
Last Updated: June 16, 2009
Health Authority: Greece: Ministry of Health and Welfare
Greece: Ethics Committee

Additional relevant MeSH terms:
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on April 22, 2014